85 related articles for article (PubMed ID: 23668218)
1. [Hotspot report of the 54th American Society of Hematology Annual Meeting Drug resistance of multiple myeloma].
Hao M; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):374-6. PubMed ID: 23668218
[No Abstract] [Full Text] [Related]
2. [Hotspot report of 54th American Society of Hematology Annual Meeting--the principle and clinical application of Bruton tyrosine kinase inhibitor].
Liu HM; Zhang YR; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):471-2. PubMed ID: 23688766
[No Abstract] [Full Text] [Related]
3. American Society of Hematology--51st annual meeting & exposition. Part 2.
Shumoogam J; Beecher N
IDrugs; 2010 Feb; 13(2):60-2. PubMed ID: 20127550
[TBL] [Abstract][Full Text] [Related]
4. [Research focus on multiple myeloma at the 53rd American Society of Hematology meeting].
Zhang KJ; Liang R; Wang LH
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):596-8. PubMed ID: 22967431
[No Abstract] [Full Text] [Related]
5. Selected abstracts on myeloma and leukemia from the American Society of Hematology annual meeting, 2003.
Oncology (Williston Park); 2004 Apr; 18(4 Suppl 2):3-42; quiz 43-4. PubMed ID: 15129679
[No Abstract] [Full Text] [Related]
6. Recent advances in the treatment of multiple myeloma. A Review of Selected Presentations From the 52nd American Society of Hematology Annual Meeting and Exposition.
Jagannath S
Clin Adv Hematol Oncol; 2011 Mar; 9(3 Suppl 4):1-16. PubMed ID: 21478821
[No Abstract] [Full Text] [Related]
7. [54th annual meeting of the Swiss Society for Internal Medicine. Annual meetings of the Swiss Society for Pneumology, the Swiss Society for Hematology, the Swiss Society for Oncology, the Swiss Society for Cardiology and the Swiss Hypertension Association. Zurich, 9-12 April 1986. Abstracts].
Schweiz Med Wochenschr Suppl; 1986; 20():1-76. PubMed ID: 3458298
[No Abstract] [Full Text] [Related]
8. [Hotspot report of 55th American Society of Hematology annual meeting: primary immune thrombocytopenia].
Peng J; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):272. PubMed ID: 24666506
[No Abstract] [Full Text] [Related]
9. [Hotspot report of 55th American Society of Hematology annual meeting: acute leukemia].
Wei H
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):270-1. PubMed ID: 24666505
[No Abstract] [Full Text] [Related]
10. Communications on multiple myeloma.
Moreau P
Expert Rev Hematol; 2009 Apr; 2(2):129-31. PubMed ID: 21083446
[TBL] [Abstract][Full Text] [Related]
11. [Hotspot report of 55th American Society of Hematology Annual Meeting: hematopoietic stem cell transplantation].
Huang X
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):269-70. PubMed ID: 24666504
[No Abstract] [Full Text] [Related]
12. The myeloma landscape in 2008.
Richardson PG
Clin Adv Hematol Oncol; 2008 Feb; 6(2 Suppl 2):1-12; quiz 15-6. PubMed ID: 18347555
[TBL] [Abstract][Full Text] [Related]
13. Clinical updates and nursing considerations for patients with multiple myeloma.
Faiman B
Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance in multiple myeloma.
Sonneveld P; Lokhorst HM; Vossebeld P
Semin Hematol; 1997 Oct; 34(4 Suppl 5):34-9. PubMed ID: 9408959
[TBL] [Abstract][Full Text] [Related]
15. [Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology].
Gotoh A; Ohyashiki K; Oshimi K; Usui N; Hotta T; Dan K; Ikeda Y; ;
Rinsho Ketsueki; 2006 Dec; 47(12):1521-7. PubMed ID: 17233470
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance in multiple myeloma.
Sonneveld P
Pathol Biol (Paris); 1999 Feb; 47(2):182-7. PubMed ID: 10192886
[TBL] [Abstract][Full Text] [Related]
17. Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.
Moschetta M; Basile A; Ferrucci A; Frassanito MA; Rao L; Ria R; Solimando AG; Giuliani N; Boccarelli A; Fumarola F; Coluccia M; Rossini B; Ruggieri S; Nico B; Maiorano E; Ribatti D; Roccaro AM; Vacca A
Clin Cancer Res; 2013 Aug; 19(16):4371-82. PubMed ID: 23804425
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant end points and new drug approvals for myeloma.
Anderson KC; Kyle RA; Rajkumar SV; Stewart AK; Weber D; Richardson P;
Leukemia; 2008 Feb; 22(2):231-9. PubMed ID: 17972944
[TBL] [Abstract][Full Text] [Related]
19. [How to overcome the cell adhesion-mediated drug resistance in multiple myeloma].
Furukawa Y; Kikuchi J
Rinsho Ketsueki; 2013 Jun; 54(6):513-21. PubMed ID: 23823089
[No Abstract] [Full Text] [Related]
20. Growth factors and antiapoptotic signaling pathways in multiple myeloma.
van de Donk NW; Lokhorst HM; Bloem AC
Leukemia; 2005 Dec; 19(12):2177-85. PubMed ID: 16239913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
